-
Esperion Therapeutics (NASDAQ:ESPR) Given Buy Rating at Needham & Company LLC
Источник: Buzz FX / 14 дек 2024 13:46:10 America/New_York
Esperion Therapeutics (NASDAQ:ESPR) Given Buy Rating at Needham & Company LLC Written by MarketBeat December 14, 2024 Share Link copied to clipboard. Esperion Therapeutics ( NASDAQ:ESPR - Get Free Report ) 's stock had its "buy" rating reis
Read more...